• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尤因肉瘤融合蛋白、EWS/Fli-1和Fli-1蛋白通过与5'启动子的ETS结构域结合来诱导PLD2而非PLD1基因的表达。

Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter.

作者信息

Kikuchi R, Murakami M, Sobue S, Iwasaki T, Hagiwara K, Takagi A, Kojima T, Asano H, Suzuki M, Banno Y, Nozawa Y, Murate T

机构信息

Nagoya University Graduate School of Medicine, Nagoya University School of Health Sciences, Nagoya, Aichi, Japan.

出版信息

Oncogene. 2007 Mar 15;26(12):1802-10. doi: 10.1038/sj.onc.1209973. Epub 2006 Sep 11.

DOI:10.1038/sj.onc.1209973
PMID:16964281
Abstract

It was reported that short interfering RNA (siRNA) of EWS/Fli-1 downregulated phospholipase D (PLD)2 in Ewing's sarcoma (EWS) cell line, suggesting that PLD2 is the target of aberrant transcription factor, EWS/Fli-1. Here, we further investigated the regulation of PLD2 gene expression by EWS/Fli-1 and Fli-1 in another EWS cell line, and also in EWS/Fli-1- or Fli-1-transfected cell line. EWS/Fli-1- or Fli-1-overexpressed cells showed higher PLD2 but not PLD1 protein expression and enhanced cell proliferation as compared to mock transfectant. The treatment of these cells with 1-butanol or siRNA of PLD2 inhibited cell growth, suggesting the pivotal role of PLD in cell growth promotion. PLD2 but not PLD1 mRNA level was also increased in EWS/Fli-1 or Fli-1-transfectants. After determining the transcription initiation points, we cloned the 5' promoter of both PLD1 and PLD2 and analysed promoter activities. Results showed that EWS/Fli-1 and Fli-1 increase PLD2 gene expression by binding to an erythroblast transformation-specific domain (-126 to -120 bp from the transcription initiation site) of PLD2 promoter, which is the minimal and most powerful region. Electrophoresis mobility shift assay using truncated proteins showed that both DNA-binding domain and trans-activating domain were necessary for the enhanced gene expression of PLD2.

摘要

据报道,尤文氏肉瘤(EWS)细胞系中EWS/Fli-1的小干扰RNA(siRNA)下调了磷脂酶D(PLD)2,这表明PLD2是异常转录因子EWS/Fli-1的靶点。在此,我们进一步研究了EWS/Fli-1和Fli-1对另一种EWS细胞系以及EWS/Fli-1或Fli-1转染细胞系中PLD2基因表达的调控。与mock转染细胞相比,过表达EWS/Fli-1或Fli-1的细胞显示出更高的PLD2蛋白表达,但PLD1蛋白表达未升高,且细胞增殖增强。用1-丁醇或PLD2的siRNA处理这些细胞可抑制细胞生长,这表明PLD在促进细胞生长中起关键作用。在EWS/Fli-1或Fli-1转染细胞中,PLD2而非PLD1的mRNA水平也有所增加。确定转录起始点后,我们克隆了PLD1和PLD2的5'启动子并分析了启动子活性。结果表明,EWS/Fli-1和Fli-1通过与PLD2启动子的成红细胞转化特异性结构域(转录起始位点上游-126至-120 bp)结合来增加PLD2基因表达,该结构域是最小且最强的区域。使用截短蛋白进行的电泳迁移率变动分析表明,DNA结合结构域和反式激活结构域对于增强PLD2的基因表达都是必需的。

相似文献

1
Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter.尤因肉瘤融合蛋白、EWS/Fli-1和Fli-1蛋白通过与5'启动子的ETS结构域结合来诱导PLD2而非PLD1基因的表达。
Oncogene. 2007 Mar 15;26(12):1802-10. doi: 10.1038/sj.onc.1209973. Epub 2006 Sep 11.
2
GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.GSTM4是一种含有微卫星的EWS/FLI靶点,参与尤因肉瘤的肿瘤发生和治疗抗性。
Oncogene. 2009 Nov 19;28(46):4126-32. doi: 10.1038/onc.2009.262. Epub 2009 Aug 31.
3
Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.肿瘤特异性EWS-ETS融合基因诱导肌腱蛋白-C的产生。
Genes Chromosomes Cancer. 2003 Mar;36(3):224-32. doi: 10.1002/gcc.10153.
4
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.编码转化生长因子-β II型受体的基因的抑制是EWS-FLI1癌蛋白的主要作用靶点。
Nat Genet. 1999 Oct;23(2):222-7. doi: 10.1038/13854.
5
Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.通过RNA干扰靶向EWS/FLI-1可在体外减弱尤因肉瘤细胞的肿瘤表型。
J Orthop Res. 2004 Jul;22(4):910-7. doi: 10.1016/j.orthres.2003.12.008.
6
Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.甲羟戊酸和N-糖基化在尤因肉瘤细胞中EWS/FLI-1融合蛋白增殖及表达中的调控作用
Exp Cell Res. 1999 Jan 10;246(1):38-46. doi: 10.1006/excr.1998.4280.
7
EWS/ETS fusions activate telomerase in Ewing's tumors.EWS/ETS融合基因在尤因肉瘤中激活端粒酶。
Cancer Res. 2003 Dec 1;63(23):8338-44.
8
Differential regulation of the response to DNA damage in Ewing's sarcoma cells by ETS1 and EWS/FLI-1.ETS1和EWS/FLI-1对尤因肉瘤细胞中DNA损伤反应的差异调节
Oncogene. 2002 Apr 25;21(18):2890-5. doi: 10.1038/sj.onc.1205393.
9
Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.多个结构域介导尤因肉瘤EWS/FLI-1融合基因的转化。
Oncogene. 1995 Feb 2;10(3):423-31.
10
A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.尤文肉瘤细胞中碱性成纤维细胞生长因子(bFGF)与EWS/FLI-1之间的联系。
Oncogene. 2000 Aug 31;19(37):4298-301. doi: 10.1038/sj.onc.1203755.

引用本文的文献

1
PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways.PLD1 是癌症干性和化疗耐药性的关键参与者:针对 PI3K/Akt 和 Wnt/β-catenin 通路之间串扰的治疗靶点。
Exp Mol Med. 2024 Jul;56(7):1479-1487. doi: 10.1038/s12276-024-01260-9. Epub 2024 Jul 1.
2
Functional regulation of phospholipase D expression in cancer and inflammation.癌症与炎症中磷脂酶D表达的功能调控
J Biol Chem. 2014 Aug 15;289(33):22575-22582. doi: 10.1074/jbc.R114.569822. Epub 2014 Jul 2.
3
The biology of ewing sarcoma.
尤因肉瘤的生物学特性
ISRN Oncol. 2013;2013:759725. doi: 10.1155/2013/759725. Epub 2013 Jan 10.
4
Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family.《化身博士》与海德先生:FUS/EWS/TAF15蛋白家族的两面性
Sarcoma. 2011;2011:837474. doi: 10.1155/2011/837474. Epub 2010 Dec 9.
5
Mesenchymal Stem Cells and the Origin of Ewing's Sarcoma.间充质干细胞与尤因肉瘤的起源
Sarcoma. 2011;2011. doi: 10.1155/2011/276463. Epub 2010 Oct 5.
6
Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.磷脂酶 D 与 Wnt 信号之间的正反馈调节促进结直肠癌细胞的 Wnt 驱动的非锚定依赖性生长。
PLoS One. 2010 Aug 12;5(8):e12109. doi: 10.1371/journal.pone.0012109.
7
New concepts in phospholipase D signaling in inflammation and cancer.炎症与癌症中磷脂酶D信号传导的新概念
ScientificWorldJournal. 2010 Jul 7;10:1356-69. doi: 10.1100/tsw.2010.116.
8
Mammalian target of rapamycin (mTOR) and S6 kinase down-regulate phospholipase D2 basal expression and function.哺乳动物雷帕霉素靶蛋白(mTOR)和 S6 激酶下调磷脂酶 D2 的基础表达和功能。
J Biol Chem. 2010 Jun 18;285(25):18991-9001. doi: 10.1074/jbc.M110.111542. Epub 2010 Apr 21.
9
A comprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation.一个全面的模型,解释了磷酸化-去磷酸化对磷脂酶 D2 活性的调节。
Mol Cell Biol. 2010 May;30(9):2251-63. doi: 10.1128/MCB.01239-09. Epub 2010 Feb 22.
10
EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo.EWS/FLI1 癌基因激活 caspase 3 转录并在体内引发细胞凋亡。
Cancer Res. 2010 Feb 1;70(3):1154-63. doi: 10.1158/0008-5472.CAN-09-1993. Epub 2010 Jan 26.